Global medical technology company Boston Scientific acquired Cosman Medical, a Burlington, Massachusetts, radiofrequency ablation system manufacturer.

We live in a society that relies on technology more with each passing day—and our healthcare system is no different. Charts are in the cloud and doctors are just a click away, but is all this technology, meant to improve care, actually taking us away from what true healthcare is about?

One of the five largest health insurers in the U.S. plans on expanding its offerings on health insurance marketplaces for 2017, going in the opposite direction of to rivals Humana and UnitedHealthcare when it comes to participation on Affordable Care Act exchanges.

Diagnosis and dectect of Alzheimer’s disease has long been problematic. Now, a new technology may use an individual's speech patterns to detect and monitor cognitive disorders, including Alzheimer’s.

The link between amyloid proteins and Alzheimer's disease is well established. Unfortunately, these structures are often only detectable once the disease has progressed to a relatively late stage. But researchers are developing a new diagnostic tool that may be capable detecting Alzheimer's in its earliest stages. 

It’s been said the nose knows—but new research details just how much our sniffers can tell us. Two studies presented July 26 at the Alzheimer’s Association International Conference examined changes in odor identification as a precursor for cognitive decline or transition to dementia.

Schneck Medical Center is using ultraviolet (UV) light to help offer its patients the cleanest environment possible. The Clorox Healthcare Optimum-UV System helps the provider take another step toward a germ-free medical center.  

The researchers, focusing on dogs between 88 and 132 lbs. who were diagnosed with bone cancer, showed that nanoparticles were capable of delivering drugs to specific tissues in the body.